Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vildagliptin and GLP-1 in T2D and Healthy Subjects
NCT02639130Phase 4Completed
- Sponsor
- Diabeteszentrum Bad Lauterberg im Harz
- Start
- Feb 2008
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vildagliptin in type 2 diabetes mellitus (T2DM), sponsored by Diabeteszentrum Bad Lauterberg im Harz. Started Feb 2008; status: completed.
02
Drugs
vildagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02639130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02639130.